Posts
October 17 2016
PFO Global, Inc. announced the closing of their PIPE offering in the amount of $431,200. EG&S acted as counsel to the Investor.
October 12 2016
Inventergy, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Company.
September 29 2016
Histogenics Corporation announced the closing of their PIPE offering in the amount of $30,000,000. EG&S acted as counsel to the Placement Agent.
September 29 2016
BioPharma X Corporation announced the closing of their Registered Direct offering in the amount of $930,000. EG&S acted as counsel to the Placement Agent.
September 28 2016
Apricus BioSciences Inc. announced the closing of their Registered Direct offering in the amount of $3,734,286. EG&S acted as counsel to the Placement Agent.
September 21 2016
OurCrowd announced the closing of their Series C Offering in the amount of $71,000,000. EG&S acted as counsel to OurCrowd.
September 19 2016
Rexahn Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Placement Agent.
September 15 2016
CytoDyn, Inc. announced the closing of their Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.